Sernova (SVA) Competitors C$0.20 +0.02 (+8.11%) As of 04/17/2025 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock SVA vs. BCT, APS, IPA, FRX, SCYB, COM, NVH, IGX, TH, and MDNAShould you be buying Sernova stock or one of its competitors? The main competitors of Sernova include BriaCell Therapeutics (BCT), Aptose Biosciences (APS), ImmunoPrecise Antibodies (IPA), Fennec Pharmaceuticals (FRX), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Theratechnologies (TH), and Medicenna Therapeutics (MDNA). These companies are all part of the "biotechnology" industry. Sernova vs. BriaCell Therapeutics Aptose Biosciences ImmunoPrecise Antibodies Fennec Pharmaceuticals Scythian Biosciences 138267 (COM.TO) Novoheart IntelGenx Technologies Theratechnologies Medicenna Therapeutics Sernova (TSE:SVA) and BriaCell Therapeutics (CVE:BCT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment, risk and community ranking. Does the MarketBeat Community believe in SVA or BCT? BriaCell Therapeutics received 29 more outperform votes than Sernova when rated by MarketBeat users. However, 91.67% of users gave Sernova an outperform vote while only 68.97% of users gave BriaCell Therapeutics an outperform vote. CompanyUnderperformOutperformSernovaOutperform Votes1191.67% Underperform Votes18.33%BriaCell TherapeuticsOutperform Votes4068.97% Underperform Votes1831.03% Do institutionals & insiders believe in SVA or BCT? 0.1% of Sernova shares are held by institutional investors. 12.1% of Sernova shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor SVA or BCT? In the previous week, BriaCell Therapeutics had 2 more articles in the media than Sernova. MarketBeat recorded 2 mentions for BriaCell Therapeutics and 0 mentions for Sernova. Sernova's average media sentiment score of 0.00 beat BriaCell Therapeutics' score of -0.66 indicating that Sernova is being referred to more favorably in the media. Company Overall Sentiment Sernova Neutral BriaCell Therapeutics Negative Which has stronger valuation and earnings, SVA or BCT? BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSernovaN/AN/A-C$35.70M-C$0.10-1.93BriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19 Do analysts rate SVA or BCT? Sernova presently has a consensus price target of C$2.00, suggesting a potential upside of 900.00%. BriaCell Therapeutics has a consensus price target of C$15.00, suggesting a potential upside of 41.51%. Given Sernova's stronger consensus rating and higher possible upside, equities research analysts plainly believe Sernova is more favorable than BriaCell Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sernova 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33BriaCell Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is SVA or BCT more profitable? Sernova's return on equity of 473.85% beat BriaCell Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets SernovaN/A 473.85% -119.26% BriaCell Therapeutics N/A N/A N/A SummarySernova beats BriaCell Therapeutics on 11 of the 14 factors compared between the two stocks. Get Sernova News Delivered to You Automatically Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SVA vs. The Competition Export to ExcelMetricSernovaBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$67.30MC$119.72MC$5.30BC$5.51BDividend Yield7.86%3.75%5.12%6.84%P/E Ratio-1.933.0521.8030.49Price / SalesN/A4,155.94379.96566.94Price / Cash6.1513.1938.2683.07Price / Book-4.6833.726.443.52Net Income-C$35.70M-C$90.50MC$3.21BC$300.18M7 Day Performance17.65%2.16%2.88%3.55%1 Month Performance8.11%-5.14%-8.63%-2.61%1 Year Performance-55.56%86.16%11.46%11.56% Sernova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SVASernovaN/AC$0.20+8.1%C$2.00+900.0%-57.0%C$67.30MN/A-1.931,959BCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195APSAptose BiosciencesN/AC$3.85-19.8%N/A-93.7%C$165.77MN/A-0.7731Gap UpHigh Trading VolumeIPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownFRXFennec PharmaceuticalsN/AC$7.58+1.7%N/A-48.6%C$146.18MC$34.86M-128.4010Gap UpSCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423,500.00-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpTHTheratechnologiesN/AC$2.35+6.8%N/A+93.3%C$74.98MC$52.22M-26.60103Analyst RevisionNews CoverageGap UpMDNAMedicenna TherapeuticsN/AC$0.93+3.3%N/A-36.4%C$69.58MC$4,868.39-2.5620Gap Down Related Companies and Tools Related Companies BriaCell Therapeutics Alternatives Aptose Biosciences Alternatives ImmunoPrecise Antibodies Alternatives Fennec Pharmaceuticals Alternatives Scythian Biosciences Alternatives 138267 (COM.TO) Alternatives Novoheart Alternatives IntelGenx Technologies Alternatives Theratechnologies Alternatives Medicenna Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:SVA) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sernova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.